Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.95
ZIMMER BIOMET HOLDINGS, INC. incurred revolving credit of $1.0 billion with JPMorgan Chase Bank, N.A. at floating rates based upon either an adjusted Term SOFR for the applicable intere maturing June 26, 2026.
- Instrument
- revolving credit
- Principal
- $1.0 billion
- Counterparty
- JPMorgan Chase Bank, N.A.
- Rate
- floating rates based upon either an adjusted Term SOFR for the applicable intere
- Maturity
- June 26, 2026
- Event
- incurrence
Exact text from the filing
The 364-Day Revolving Credit Agreement, dated as of June 27, 2025, among the Company, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent (the “364-Day Credit Agreement”), is an unsecured revolving credit facility in the principal amount of $1.0 billion (the “364-Day Revolving Facility”).
View on SEC.gov
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.95
ZIMMER BIOMET HOLDINGS, INC. incurred revolving credit of $1.5 billion with JPMorgan Chase Bank, N.A. at floating rates based upon either an adjusted Term SOFR for the applicable intere maturing June 27, 2030.
- Instrument
- revolving credit
- Principal
- $1.5 billion
- Counterparty
- JPMorgan Chase Bank, N.A.
- Rate
- floating rates based upon either an adjusted Term SOFR for the applicable intere
- Maturity
- June 27, 2030
- Event
- incurrence
Exact text from the filing
the Company, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent (the “Five-Year Credit Agreement”), is a five-year unsecured revolving facility of $1.5 billion (the “Five-Year Revolving Facility”). The Five-Year Credit Agreement will mature on June 27, 2030, with two one-year extensions exercisable at the Company’s discretion and
View on SEC.gov